Global Cetirizine Hydrochloride API Market Growth 2025-2031

Publication ID:

LPI06250081

Publication Date:

June 2, 2025

Pages:

136

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Cetirizine Hydrochloride API market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淐etirizine Hydrochloride API Industry Forecast鈥� looks at past sales and reviews total world Cetirizine Hydrochloride API sales in 2024, providing a comprehensive analysis by region and market sector of projected Cetirizine Hydrochloride API sales for 2025 through 2031. With Cetirizine Hydrochloride API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cetirizine Hydrochloride API industry.
This Insight Report provides a comprehensive analysis of the global Cetirizine Hydrochloride API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cetirizine Hydrochloride API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Cetirizine Hydrochloride API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cetirizine Hydrochloride API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cetirizine Hydrochloride API.
This report presents a comprehensive overview, market shares, and growth opportunities of Cetirizine Hydrochloride API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
笔耻谤颈迟测鈮�99%
Purity<99%
Segmentation by Application:
Tablet
Capsule
Oral Syrup
Solution
Ophthalmic Drops
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Granules India Ltd
Thinq Pharma-Cro Ltd
Unichem Laboratories Ltd
Dishman Carbogen Amcis Ltd
Ipca Laboratories Ltd
Solara Active Pharma Sciences Ltd
Mylan Laboratories Ltd
Ucb Pharma Sa
M/s. Granules India Limited
Nanjing Shenghe Pharmaceutical
Jiangsu Lianhuan Pharmaceutical
Zhejiang Warner Pharmaceuticals
Hunan Xiangyikang Pharmaceutical
Jiangsu Hengrui Medicine
Chongqing Southwest Synthetic Pharmaceutical
Lunan Beit Pharmaceutical
Qilu Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Cetirizine Hydrochloride API market?
What factors are driving Cetirizine Hydrochloride API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Cetirizine Hydrochloride API market opportunities vary by end market size?
How does Cetirizine Hydrochloride API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cetirizine Hydrochloride API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Cetirizine Hydrochloride API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Cetirizine Hydrochloride API by Country/Region, 2020, 2024 & 2031
2.2 Cetirizine Hydrochloride API Segment by Type
2.2.1 笔耻谤颈迟测鈮�99%
2.2.2 Purity<99%
2.3 Cetirizine Hydrochloride API Sales by Type
2.3.1 Global Cetirizine Hydrochloride API Sales Market Share by Type (2020-2025)
2.3.2 Global Cetirizine Hydrochloride API Revenue and Market Share by Type (2020-2025)
2.3.3 Global Cetirizine Hydrochloride API Sale Price by Type (2020-2025)
2.4 Cetirizine Hydrochloride API Segment by Application
2.4.1 Tablet
2.4.2 Capsule
2.4.3 Oral Syrup
2.4.4 Solution
2.4.5 Ophthalmic Drops
2.5 Cetirizine Hydrochloride API Sales by Application
2.5.1 Global Cetirizine Hydrochloride API Sale Market Share by Application (2020-2025)
2.5.2 Global Cetirizine Hydrochloride API Revenue and Market Share by Application (2020-2025)
2.5.3 Global Cetirizine Hydrochloride API Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Cetirizine Hydrochloride API Breakdown Data by Company
3.1.1 Global Cetirizine Hydrochloride API Annual Sales by Company (2020-2025)
3.1.2 Global Cetirizine Hydrochloride API Sales Market Share by Company (2020-2025)
3.2 Global Cetirizine Hydrochloride API Annual Revenue by Company (2020-2025)
3.2.1 Global Cetirizine Hydrochloride API Revenue by Company (2020-2025)
3.2.2 Global Cetirizine Hydrochloride API Revenue Market Share by Company (2020-2025)
3.3 Global Cetirizine Hydrochloride API Sale Price by Company
3.4 Key Manufacturers Cetirizine Hydrochloride API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cetirizine Hydrochloride API Product Location Distribution
3.4.2 Players Cetirizine Hydrochloride API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Cetirizine Hydrochloride API by Geographic Region
4.1 World Historic Cetirizine Hydrochloride API Market Size by Geographic Region (2020-2025)
4.1.1 Global Cetirizine Hydrochloride API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Cetirizine Hydrochloride API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Cetirizine Hydrochloride API Market Size by Country/Region (2020-2025)
4.2.1 Global Cetirizine Hydrochloride API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Cetirizine Hydrochloride API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Cetirizine Hydrochloride API Sales Growth
4.4 APAC Cetirizine Hydrochloride API Sales Growth
4.5 Europe Cetirizine Hydrochloride API Sales Growth
4.6 Middle East & Africa Cetirizine Hydrochloride API Sales Growth
5 Americas
5.1 Americas Cetirizine Hydrochloride API Sales by Country
5.1.1 Americas Cetirizine Hydrochloride API Sales by Country (2020-2025)
5.1.2 Americas Cetirizine Hydrochloride API Revenue by Country (2020-2025)
5.2 Americas Cetirizine Hydrochloride API Sales by Type (2020-2025)
5.3 Americas Cetirizine Hydrochloride API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cetirizine Hydrochloride API Sales by Region
6.1.1 APAC Cetirizine Hydrochloride API Sales by Region (2020-2025)
6.1.2 APAC Cetirizine Hydrochloride API Revenue by Region (2020-2025)
6.2 APAC Cetirizine Hydrochloride API Sales by Type (2020-2025)
6.3 APAC Cetirizine Hydrochloride API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cetirizine Hydrochloride API by Country
7.1.1 Europe Cetirizine Hydrochloride API Sales by Country (2020-2025)
7.1.2 Europe Cetirizine Hydrochloride API Revenue by Country (2020-2025)
7.2 Europe Cetirizine Hydrochloride API Sales by Type (2020-2025)
7.3 Europe Cetirizine Hydrochloride API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cetirizine Hydrochloride API by Country
8.1.1 Middle East & Africa Cetirizine Hydrochloride API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Cetirizine Hydrochloride API Revenue by Country (2020-2025)
8.2 Middle East & Africa Cetirizine Hydrochloride API Sales by Type (2020-2025)
8.3 Middle East & Africa Cetirizine Hydrochloride API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cetirizine Hydrochloride API
10.3 Manufacturing Process Analysis of Cetirizine Hydrochloride API
10.4 Industry Chain Structure of Cetirizine Hydrochloride API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cetirizine Hydrochloride API Distributors
11.3 Cetirizine Hydrochloride API Customer
12 World Forecast Review for Cetirizine Hydrochloride API by Geographic Region
12.1 Global Cetirizine Hydrochloride API Market Size Forecast by Region
12.1.1 Global Cetirizine Hydrochloride API Forecast by Region (2026-2031)
12.1.2 Global Cetirizine Hydrochloride API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Cetirizine Hydrochloride API Forecast by Type (2026-2031)
12.7 Global Cetirizine Hydrochloride API Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Granules India Ltd
13.1.1 Granules India Ltd Company Information
13.1.2 Granules India Ltd Cetirizine Hydrochloride API Product Portfolios and Specifications
13.1.3 Granules India Ltd Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Granules India Ltd Main Business Overview
13.1.5 Granules India Ltd Latest Developments
13.2 Thinq Pharma-Cro Ltd
13.2.1 Thinq Pharma-Cro Ltd Company Information
13.2.2 Thinq Pharma-Cro Ltd Cetirizine Hydrochloride API Product Portfolios and Specifications
13.2.3 Thinq Pharma-Cro Ltd Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Thinq Pharma-Cro Ltd Main Business Overview
13.2.5 Thinq Pharma-Cro Ltd Latest Developments
13.3 Unichem Laboratories Ltd
13.3.1 Unichem Laboratories Ltd Company Information
13.3.2 Unichem Laboratories Ltd Cetirizine Hydrochloride API Product Portfolios and Specifications
13.3.3 Unichem Laboratories Ltd Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Unichem Laboratories Ltd Main Business Overview
13.3.5 Unichem Laboratories Ltd Latest Developments
13.4 Dishman Carbogen Amcis Ltd
13.4.1 Dishman Carbogen Amcis Ltd Company Information
13.4.2 Dishman Carbogen Amcis Ltd Cetirizine Hydrochloride API Product Portfolios and Specifications
13.4.3 Dishman Carbogen Amcis Ltd Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Dishman Carbogen Amcis Ltd Main Business Overview
13.4.5 Dishman Carbogen Amcis Ltd Latest Developments
13.5 Ipca Laboratories Ltd
13.5.1 Ipca Laboratories Ltd Company Information
13.5.2 Ipca Laboratories Ltd Cetirizine Hydrochloride API Product Portfolios and Specifications
13.5.3 Ipca Laboratories Ltd Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ipca Laboratories Ltd Main Business Overview
13.5.5 Ipca Laboratories Ltd Latest Developments
13.6 Solara Active Pharma Sciences Ltd
13.6.1 Solara Active Pharma Sciences Ltd Company Information
13.6.2 Solara Active Pharma Sciences Ltd Cetirizine Hydrochloride API Product Portfolios and Specifications
13.6.3 Solara Active Pharma Sciences Ltd Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Solara Active Pharma Sciences Ltd Main Business Overview
13.6.5 Solara Active Pharma Sciences Ltd Latest Developments
13.7 Mylan Laboratories Ltd
13.7.1 Mylan Laboratories Ltd Company Information
13.7.2 Mylan Laboratories Ltd Cetirizine Hydrochloride API Product Portfolios and Specifications
13.7.3 Mylan Laboratories Ltd Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Mylan Laboratories Ltd Main Business Overview
13.7.5 Mylan Laboratories Ltd Latest Developments
13.8 Ucb Pharma Sa
13.8.1 Ucb Pharma Sa Company Information
13.8.2 Ucb Pharma Sa Cetirizine Hydrochloride API Product Portfolios and Specifications
13.8.3 Ucb Pharma Sa Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ucb Pharma Sa Main Business Overview
13.8.5 Ucb Pharma Sa Latest Developments
13.9 M/s. Granules India Limited
13.9.1 M/s. Granules India Limited Company Information
13.9.2 M/s. Granules India Limited Cetirizine Hydrochloride API Product Portfolios and Specifications
13.9.3 M/s. Granules India Limited Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 M/s. Granules India Limited Main Business Overview
13.9.5 M/s. Granules India Limited Latest Developments
13.10 Nanjing Shenghe Pharmaceutical
13.10.1 Nanjing Shenghe Pharmaceutical Company Information
13.10.2 Nanjing Shenghe Pharmaceutical Cetirizine Hydrochloride API Product Portfolios and Specifications
13.10.3 Nanjing Shenghe Pharmaceutical Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Nanjing Shenghe Pharmaceutical Main Business Overview
13.10.5 Nanjing Shenghe Pharmaceutical Latest Developments
13.11 Jiangsu Lianhuan Pharmaceutical
13.11.1 Jiangsu Lianhuan Pharmaceutical Company Information
13.11.2 Jiangsu Lianhuan Pharmaceutical Cetirizine Hydrochloride API Product Portfolios and Specifications
13.11.3 Jiangsu Lianhuan Pharmaceutical Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Jiangsu Lianhuan Pharmaceutical Main Business Overview
13.11.5 Jiangsu Lianhuan Pharmaceutical Latest Developments
13.12 Zhejiang Warner Pharmaceuticals
13.12.1 Zhejiang Warner Pharmaceuticals Company Information
13.12.2 Zhejiang Warner Pharmaceuticals Cetirizine Hydrochloride API Product Portfolios and Specifications
13.12.3 Zhejiang Warner Pharmaceuticals Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Zhejiang Warner Pharmaceuticals Main Business Overview
13.12.5 Zhejiang Warner Pharmaceuticals Latest Developments
13.13 Hunan Xiangyikang Pharmaceutical
13.13.1 Hunan Xiangyikang Pharmaceutical Company Information
13.13.2 Hunan Xiangyikang Pharmaceutical Cetirizine Hydrochloride API Product Portfolios and Specifications
13.13.3 Hunan Xiangyikang Pharmaceutical Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hunan Xiangyikang Pharmaceutical Main Business Overview
13.13.5 Hunan Xiangyikang Pharmaceutical Latest Developments
13.14 Jiangsu Hengrui Medicine
13.14.1 Jiangsu Hengrui Medicine Company Information
13.14.2 Jiangsu Hengrui Medicine Cetirizine Hydrochloride API Product Portfolios and Specifications
13.14.3 Jiangsu Hengrui Medicine Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Jiangsu Hengrui Medicine Main Business Overview
13.14.5 Jiangsu Hengrui Medicine Latest Developments
13.15 Chongqing Southwest Synthetic Pharmaceutical
13.15.1 Chongqing Southwest Synthetic Pharmaceutical Company Information
13.15.2 Chongqing Southwest Synthetic Pharmaceutical Cetirizine Hydrochloride API Product Portfolios and Specifications
13.15.3 Chongqing Southwest Synthetic Pharmaceutical Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Chongqing Southwest Synthetic Pharmaceutical Main Business Overview
13.15.5 Chongqing Southwest Synthetic Pharmaceutical Latest Developments
13.16 Lunan Beit Pharmaceutical
13.16.1 Lunan Beit Pharmaceutical Company Information
13.16.2 Lunan Beit Pharmaceutical Cetirizine Hydrochloride API Product Portfolios and Specifications
13.16.3 Lunan Beit Pharmaceutical Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Lunan Beit Pharmaceutical Main Business Overview
13.16.5 Lunan Beit Pharmaceutical Latest Developments
13.17 Qilu Pharmaceutical
13.17.1 Qilu Pharmaceutical Company Information
13.17.2 Qilu Pharmaceutical Cetirizine Hydrochloride API Product Portfolios and Specifications
13.17.3 Qilu Pharmaceutical Cetirizine Hydrochloride API Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Qilu Pharmaceutical Main Business Overview
13.17.5 Qilu Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂